Today: 2 February 2026
Subscribe
Browse Category

NASDAQ:ERAS News 14 January 2026

Erasca stock jumps 10% as Wall Street lifts targets to $11 on ERAS-0015 data

Erasca stock jumps 10% as Wall Street lifts targets to $11 on ERAS-0015 data

New York, Jan 14, 2026, 12:38 PM ET — Regular session Shares of Erasca Inc jumped roughly 10% Wednesday, pushing higher after a string of price-target upgrades fueled by early trial results. The clinical-stage cancer drugmaker’s stock hit $8.29, up 10.5%. The significance lies in Erasca having no approved products. In early-stage biotech, just a few signs of tumor shrinkage…
14 January 2026
·····

Stock Market Today

  • Frank Rimerman Advisors Increases Pfizer Stake by 27.6% in Q3
    February 2, 2026, 10:43 AM EST. Frank Rimerman Advisors LLC raised its Pfizer Inc. (NYSE:PFE) holdings by 27.6% in the third quarter, acquiring 42,634 additional shares to hold 196,970 in total, valued at about $5.02 million. Other institutional investors also boosted positions, including Fiduciary Alliance LLC (+46.4%), Vista Investment Partners LLC (+236.1%), and Generali Investments (+76.4%). Pfizer, a major biopharmaceutical firm, reported Q3 earnings surpassing estimates with $0.87 EPS versus $0.79 expected, though revenue of $16.65 billion missed forecasts. The stock trades near a 1-year high at $26.43, holding a market cap of $150.24 billion alongside a P/E ratio of 15.36. Institutional investors currently own 68.36% of Pfizer shares.
Go toTop